Inferior Vena Cava Filters in Recurrent Thromboembolism: Yes or No?

Courtesy of Dr. Guillermo Migliaro.

vena cava filters, pulmonary embolism, deep vein thrombosisAt present, there is no clear evidence in favor of inferior vena cava filters (IVC) for patients developing recurrent symptomatic venous thromboembolism (VTE), and the existing guideline recommendations from the different societies are contradicting.

 

The aim of this study was to assess the effectiveness of these devices in patients with recurrent VTE on anticoagulant therapy. The study incorporated patients with IVC filters for recurrent venous thromboembolism in the first three months of anticoagulant therapy from the RIETE registry (Registro Informatizado de la Enfermedad Tromboembólica) and locked at mortality outcomes 30 days after diagnosis, as follows:

  • all cause
  • pulmonary embolism related
  • second recurrent venous thromboembolism episode
  • major bleeding

 

Among 17 patients treated with filters and 49 matched patients treated without filters for VTE recurrence that presented as deep vein thrombosis, propensity score matching showed no significant differences in mortality (17.7% vs. 12.2%; p = 0.56).

 

When recurrent thromboembolism presented as pulmonary embolism (48 with VCF and 91 matched patients treated without VCF) there was a significant reduction in all-cause mortality: 2.1% vs. 25.3%; p = 0.02).

 

Pulmonary embolism related mortality was not significantly lower in the VCF group (2.1% vs. 17.6%; p = 0.08).

 

The authors concluded that, during the first three months of anticoagulation therapy, VCF placement in patients with recurrent VTE was associated to a benefit in survival rate in patients presenting pulmonary embolism..

 

Editorial Comment

Surprisingly, there is little evidence on inferior vena cava filters in patients with recurrent thromboembolism. The study sheds some light on a scarcely studied matter. The number of patients is small and the cause behind recurrent thromboembolism has not yet been determined and, although VCFs seem to be somewhat beneficial for patients with pulmonary embolism, the evidence is not enough for us to advocate for filters.

 

Courtesy of Dr. Guillermo Migliaro. German Hospital, Buenos Aires, Argentina.

 

Original Title: Outcomes Associated with Inferior Vena Cava Filters among Patients with Thromboembolic Recurrence During Anticoagulant Therapy.

Reference: M Mellado et al. JACC Cardiovasc Interv. 2016 Nov 3.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

A New Asymptomatic Carotid Stenosis Paradigm? CREST-2 Trial Unified Results

Severe asymptomatic carotid stenosis continues to be controversial seeing the optimization of intensive medical therapy (IMT) and the availability lower periprocedural risk revascularization techniques....

Impact of Baseline Systolic Blood Pressure on Blood Pressure Changes Following Renal Denervation

Renal denervation (RDN) is a guideline-recommended therapy to reduce blood pressure in patients with uncontrolled hypertension, although uncertainties remain regarding which factors best predict...

Hypertriglyceridemia as Key Factor to Abdominal Aortic Aneurysm Development and Rupture: Genetic and Experimental Evidence

Abdominal aortic aneurysm (AAA) is a deadly vascular disease with no effective drug treatment, and risk of rupture reaching up to 80%. Even though...

Atrial Fibrillation and Chronic Kidney Disease: Outcomes of Different Stroke Prevention Strategies

Atrial fibrillation (AF) affects approximately 1 in every 4 patients with end-stage renal disease (ESRD). This population carries a high burden of comorbidities and...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

COILSEAL: Use of Coils in Percutaneous Coronary Intervention, Useful for Complication Management?

The use of coils as vascular closing tool has been steadily expanding beyond its traditional role in neuroradiology into coronary territory, where it remains...

Treatment of In-Stent Restenosis in Small Vessels with Paclitaxel-Coated Balloons

Coronary artery disease (CAD) in smaller epicardial vessels occurs in 30% to 67% of patients undergoing percutaneous coronary intervention and poses particular technical challenges....

Contemporary Challenges in Left Atrial Appendage Closure: Updated Approach to Device Embolization

Even though percutaneous left atrial appendage (LAA) closure is generally safe, device embolization – with 0 to 1.5% global incidence – is still a...